Ukrainian Journal Health of Woman. 2026. 1(182): 86-90. doi: 10.15574/HW.2026.1(182).8690
Shulhina V. V., Tokar P. Yu.
Bukovinian State Medical University, Chernivtsi, Ukraine

For citation: Shulhina VV, Tokar PYu. (2026). Global disparities and trends in cervical cancer morbidity and mortality. Ukrainian Journal Health of Woman. 1(182): 86-90. doi: 10.15574/HW.2026.1(182).8690
Article received: Nov 25, 2025. Accepted for publication: Jan 28, 2026.

Cervical cancer remains one of the leading causes of morbidity and mortality among women worldwide, despite the availability of effective prevention methods such as human papillomavirus (HPV) vaccination and screening programs. High-income countries have seen significant declines in recent decades, while the burden of disease remains critically high in low- and middle-income countries, underscoring global health inequalities.
Aim – to analyze global trends in morbidity and mortality from cervical cancer, as well as to assess regional disparities and factors affecting their formation.
A systematic literature review was conducted using the Scopus, PubMed, and Web of Science databases for the period 2000-2025. The search was carried out using the keywords "cervical cancer", "incidence", "mortality", "epidemiology", and "global trends". The analysis included peer-reviewed articles in English that contained epidemiological data at the global or regional levels. The selection of studies was carried out in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations, followed by a qualitative synthesis of the results. The analysis showed significant unevenness in the distribution of morbidity and mortality from cervical cancer. In high-income countries, rates have declined with the introduction of HPV screening and vaccination. At the same time, low- and middle-income countries, particularly in Africa and Southeast Asia, continue to have high rates of morbidity and mortality. Determining factors include limited access to health services, low vaccination coverage, and socio-economic barriers.
Conclusions. Cervical cancer remains a significant global problem with marked regional disparities. There is a need to expand HPV vaccination programs, increase the availability of screening, and implement effective early diagnosis strategies, especially in low- and middle-income countries.
No conflict of interests was declared by the authors.
Keywords: cervical cancer, morbidity, mortality, epidemiology, global trends.

REFERENCES

1. Gapare CR, El-Zein M, Patel H, Tope P, Franco EL. (2022). Ecologic Analysis of Correlates of Cervical Cancer Morbidity and Mortality in Sub-Saharan Africa. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 31(9): 1804-1811. https://doi.org/10.1158/1055-9965.EPI-22-0193; PMid:35700009

2. He WQ, Li C. (2021). Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends. Gynecologic oncology. 163(3): 583-592. https://doi.org/10.1016/j.ygyno.2021.10.075; PMid:34688503

3. Huang J, Deng Y, Boakye D, Tin MS, Lok V, Zhang L et al. (2022). Global distribution, risk factors, and recent trends for cervical cancer: A worldwide country-level analysis. Gynecologic oncology. 164(1): 85-92. https://doi.org/10.1016/j.ygyno.2021.11.005; PMid:34799136

4. Kenealy BP, Lochner JE. (2025). Cancer Screening in Women. Primary care. 52(2): 233-248. https://doi.org/10.1016/j.pop.2024.12.007; PMid:40412903

5. Lin S, Gao K, Gu S, You L, Qian S, Tang M et al. (2021). Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years. Cancer. 127(21): 4030-4039. https://doi.org/10.1002/cncr.33795; PMid:34368955

6. Li T, Zhang H, Lian M, He Q, Lv M, Zhai L et al. (2025). Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021. Journal of hematology & oncology. 18(1): 5. https://doi.org/10.1186/s13045-025-01660-y; PMid:39794860 PMCid:PMC11721161

7. Li Z, Liu P, Yin A, Zhang B, Xu J, Chen Z et al. (2025). Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer. International journal of cancer. 157(2): 288-297. https://doi.org/10.1002/ijc.35369; PMid:40026066

8. Luu XQ, Jun JK, Suh M, Oh JK, Yu SY, Choi KS. (2025). Cervical Cancer Screening, HPV Vaccination, and Cervical Cancer Elimination. JAMA network open. 8(8): e2526683. https://doi.org/10.1001/jamanetworkopen.2025.26683; PMid:40794406 PMCid:PMC12344532

9. Malagón T, Franco EL, Tejada R, Vaccarella S. (2024). Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nature reviews. Clinical oncology. 21(7): 522-538. https://doi.org/10.1038/s41571-024-00904-z; PMid:38760499

10. Momenimovahed Z, Mazidimoradi A, Maroofi P, Allahqoli L, Salehiniya H, Alkatout I. (2023). Global, regional and national burden, incidence, and mortality of cervical cancer. Cancer reports (Hoboken, N.J.). 6(3): e1756. https://doi.org/10.1002/cnr2.1756; PMid:36545760 PMCid:PMC10026270

11. Pei J, Li M, Wu C, Xu M, Shu T, Zhu C. (2022). Worldwide trends in cervical cancer incidence and mortality. Cancer. 128(5): 1141. https://doi.org/10.1002/cncr.34029; PMid:34817879

12. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B et al. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. The Lancet. Global health. 11(2): e197-e206. https://doi.org/10.1016/S2214-109X(22)00501-0; PMid:36528031 PMCid:PMC9848409

13. Tokar, P. (2025). cervical cancer in the structure of malignant neoplasms in Ukraine: results of an epidemiological study, 2014-2023. The Medical and Ecological Problems. 29(3): 31-42. https://doi.org/10.31718/mep.2025.29.3.05

14. Ueda Y. (2024). Epidemiology of cervical cancer and HPV infection in Asia and Oceania. The journal of obstetrics and gynaecology research. 50; Suppl 1: 31-41. https://doi.org/10.1111/jog.15943; PMid:38589341

15. Zhang Y, Fan Z, Wang J, Guan B, Zhou F, Tang Z et al. (2025). HPV vaccination, screening disparities, and the shifting landscape of cervical cancer burden: a global analysis of trends, inequalities, and policy implications. BMC women's health. 25(1): 285. https://doi.org/10.1186/s12905-025-03841-w; PMid:40484937 PMCid:PMC12147263